目的 对鄂尔多斯市中心医院人血白蛋白的临床使用情况进行分析，为临床合理用药提供支持。方法 抽取2015年鄂尔多斯市中心医院使用人血白蛋白注射液的住院患者病历1 081份，对患者的基本情况，人血白蛋白的使用科室、用药原因和血清白蛋白的浓度检测等数据进行统计分析。结果 人血白蛋白的使用患者年龄集中于60岁以上，构成比为64.38%。用药人数和用药总量较多的科室均为普通外科、重症监护室、肾内科；用药原因以营养支持所占比例最大，为34.32%；用药中血清白蛋白浓度>40.00 g/L的患者为127例，占11.75%，227例患者未检测血清白蛋白浓度。结论 鄂尔多斯市中心医院人血白蛋白在临床应用中存在一些误区，无指征用药、未进行血清白蛋白浓度检测等现象仍然存在，应加强监督管理，促进合理用药。

Objective To investigate the application of human albumin in Ordos Central Hospital, and to provide support for rational use of drugs in clinic. Methods In-patients (1081 cases) using Human Albumin Injection in Ordos Central Hospital in 2015 were randomly extracted. General information of patients, medicine departments and reasons of the use of human albumin, and concentration detection of serum albumin were analyzed statistically. Results Patients using human albumin were focused on the patients who are over 60 years old, and the constituent ratio was 64.38%. The departments with more number of patients and total dose were Department of General Surgery, Intensive Care Unit, and Department of Nephrology. Nutritional support (34.32%) accounted for the maximum ratio of medical reasons. The cases of patients with concentration of serum albumin in the medication above 40 g/L were 127, accounting for 11.75%. There were 227 cases of patients who were not detected the concentration of serum albumin. Conclusion There are still some misunderstandings in the application of human serum albumin in Ordos Central Hospital, such as no indication of medicine and not detecting the concentration of serum albumin. Therefore, the management of human albumin should be strengthened, and to promote reasonable use of drugs.